These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9247912)

  • 1. A hypothesis to explain the role of the suppressor and helper T cells in the immunologic selection of highly related human immunodeficiency virus isolates found in infected patients.
    Barnett E; Barnett N
    Med Hypotheses; 1997 Jul; 49(1):77-9. PubMed ID: 9247912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
    McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P
    Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities.
    Andrews CA; Sullivan JL; Brettler DB; Brewster FE; Forsberg AD; Scesney S; Levine PH
    J Pediatr; 1987 Nov; 111(5):672-7. PubMed ID: 2959763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunology of HIV infection.
    Zunich KM; Lane HC
    J Am Acad Dermatol; 1990 Jun; 22(6 Pt 2):1202-5. PubMed ID: 2141867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to human immunodeficiency virus correlates with decreased T helper lymphocytes in asymptomatic individuals.
    Weiser B; Burger H; Steimer K; Lifson J; Engleman E; Grimson R; Robinson WS
    J Med Virol; 1987 Jul; 22(3):237-44. PubMed ID: 2957464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses.
    Clerici M; Roilides E; Via CS; Pizzo PA; Shearer GM
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8424-8. PubMed ID: 1388269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can immune responses to human immunodeficiency virus be preserved, enhanced, or restored?
    Walker BD
    AIDS Clin Rev; 2000-2001; ():101-14. PubMed ID: 10999218
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.
    Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
    Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
    Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1.
    Leandersson AC; Gilljam G; Fredriksson M; Hinkula J; Alaeus A; Lidman K; Albert J; Bratt G; Sandström E; Wahren B
    J Virol; 2000 May; 74(10):4888-90. PubMed ID: 10775629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction.
    Brocca-Cofano E; Kuhrt D; Siewe B; Xu C; Haret-Richter GS; Craigo J; Labranche C; Montefiori DC; Landay A; Apetrei C; Pandrea I
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.
    Clerici M; Stocks NI; Zajac RA; Boswell RN; Bernstein DC; Mann DL; Shearer GM; Berzofsky JA
    Nature; 1989 Jun; 339(6223):383-5. PubMed ID: 2524668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunopathogenesis and therapeutic approaches in acquired immunologic deficiency syndrome (AIDS)].
    Zielinski C
    Acta Med Austriaca; 1987; 14(1):5-9. PubMed ID: 2956821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of escape mutants from immune recognition during HIV infection.
    Bernaschi M; Castiglione F
    Immunol Cell Biol; 2002 Jun; 80(3):307-13. PubMed ID: 12067418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale for immunotherapy in HIV-1 infection.
    Walker BD
    J Acquir Immune Defic Syndr (1988); 1994; 7 Suppl 1():S6-13. PubMed ID: 8182510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological features of human immunodeficiency virus disease.
    Seligmann M
    Baillieres Clin Haematol; 1990 Jan; 3(1):37-63. PubMed ID: 2138920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulation, immune defects, and clinical strategies in HIV infection.
    Lane HC
    Mt Sinai J Med; 1992 May; 59(3):244-52. PubMed ID: 1534869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
    Kumar A; Buch S; Foresman L; Bischofberger N; Lifson JD; Narayan O
    Virology; 2001 Jan; 279(1):97-108. PubMed ID: 11145893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.